Another study revealed that the anti-obesity effect of ADSCs was due to decreased lipogenesis and increased lipolysis through hormone-sensitive lipase activation and acetyl-CoA carboxylase1 suppression [18]. The gene discussed is LIPE; the disease is obesity due to melanocortin 4 receptor deficiency.